ABOUT
Smart discussion of the latest science and news on toxins in your food, water, and air, and what government agencies should be doing to protect public health. Written by EWG staff.
DONATE TO EWG!
Help us protect your health and environment! Please donate $5 to EWG today.
GET EWG'S TIPS & ACTION ALERTS
Sign Up here to receive email updates and tips from EWG and stay informed on the issues that matter most to you.
ENVIROBLOG VIA EMAIL
Join EWG's live chat with Chef Ann Cooper
School lunch: More fruits & veggies, please!
Texas Schools are Drilling for Dollars
Why do blowouts take so long to fix?
SEARCH ENVIROBLOG
FEATURED
Support the 2010 Safe Cosmetics Act. It's Urgent.
Why, oh why is there plastic in my aluminum water bottle?
Cell phone radiation series - Part 2: 8 Ways to reduce your exposure
Test Your Knowledge of Cosmetics Safety: 8 Myths Debunked
EWG's Tips for Parents: The Series
EWG's Tips to avoid BPA exposure
EWG on TV
Cutting the Pork from U.S. Farm Bill
Sunscreen safety & DC drinking water
Perchlorate in people, kids' personal care products & plastics, and sunscreen
BPA in baby formula & safe cosmetics
What can I do about fluoride in my water?
What is new carpet treated with? What can I do?
Are stainless steel water bottles safe?
Is mineral-based makeup safer?
PEOPLE TALKING TOXICS
TALK TO US
Did we miss something? Email Enviroblog.
« RAN's World Rainforest Week | Main | Drink me, I'm toxic »
Preschool puberty from cometics, drugs
Today the New York Times reports some disturbing news about certain drugs and cosmetics causing preschoolers to go into puberty. In one case, a girl and her brother--whose father had been using a testosterone skin cream--started growing pubic hair just from skin contact with their father. Her brother also developed some aggressive behavior problems. The article cites some 1998 cases of early breast development in young girls brought on by a shampoo which contained estrogen and placental extract.
What does the FDA have to say about this? The FDA spokesperson told the Times that FDA was “aware of some reports describing premature sexual development” and that “there is no reason for consumers to be concerned.” And at this time “placental materials are neither prohibited by cosmetic regulations nor restricted” by the FDA.
Robert Cooper, chief of endocrinology at the reproductive toxicology division of the EPA suggests that conflicts of interest on advisory panels have hampered the development of adequate testing measures for these endocrine disruptors in consumer products:
In 1996, Congress directed the E.P.A. to develop a comprehensive screening program for possible endocrine disruptors within three years. Dr. Cooper says no such program has begun operation, a failure he attributed largely to stonewalling by chemical industry representatives who serve on an advisory committee for the program. Now the proposed rollout is December 2007, but Dr. Cooper said, “They may be dreaming.” Critics cite the program’s high potential costs and lack of reliable laboratory tests.
Full article
Leave a comment